dc.contributor.author | Kaymak, Cetin | |
dc.contributor.author | Yilmaz, Erdal | |
dc.contributor.author | Basar, Hulya | |
dc.contributor.author | Ozcakir, Sibel | |
dc.contributor.author | Apan, Alpaslan | |
dc.contributor.author | Batislam, Ertan | |
dc.date.accessioned | 2020-06-25T17:44:00Z | |
dc.date.available | 2020-06-25T17:44:00Z | |
dc.date.issued | 2007 | |
dc.identifier.issn | 0892-7790 | |
dc.identifier.issn | 1557-900X | |
dc.identifier.uri | https://doi.org10.1089/end.2006.0195 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/3977 | |
dc.description | Batislam, Ertan/0000-0002-7493-4573 | en_US |
dc.description | WOS: 000244914800038 | en_US |
dc.description | PubMed: 17338610 | en_US |
dc.description.abstract | Purpose: To assess whether intravenous magnesium sulfate infusion affects analgesic requirements during monitored anesthesia care (MAC) for shockwave lithotripsy (SWL). Patients and Methods: Fifty patients in ASA class I or II undergoing SWL with MAC were randomized into two groups. Induction of MAC was produced by bolus doses of midazolam 0.03 mg/kg(-1) and fentanyl 0.5 mu g/kg(-1) followed by intravenous infusion of midazolam 0.015 to 0.06 mg/kg(-1)/hr(-1) with fentanyl supplementation 0.2 mu g/kg(-1). In addition, group I patients received magnesium sulfate 30 mg/kg(-1) intravenously as a bolus dose followed by a continuous infusion of 10 mg/kg(-1) /hr(-1) beginning 15 minutes before induction of sedation. The midazolam infusion rate and additional fentanyl doses were adjusted by verbal analog scale (VAS) measurements, observer assessment sedation score (OAA/S), and achieving a target bispectral index (BIS) in a range of 70 to 90. At the end of SWL, the total midazolam and total fentanyl consumptions were recorded, and the serum magnesium concentration was measured. Results: Magnesium caused significant decreases in the total consumption of midazolam (P = 0.001) and fentanyl (P = 0.001). The VAS values at the 15th, 20th, and 25th minute in group I were significantly lower than in group II. In group I, hemodynamic and arterial oxygen parameters were better than in group II. Conclusion: A magnesium bolus and infusion can be utilized to reduce analgesic requirements under MAC during SWL. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Mary Ann Liebert, Inc | en_US |
dc.relation.isversionof | 10.1089/end.2006.0195 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Use of the NMDA antagonist magnesium sulfate during monitored anesthesia care for shockwave lithotripsy | en_US |
dc.type | article | en_US |
dc.identifier.volume | 21 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 145 | en_US |
dc.identifier.endpage | 150 | en_US |
dc.relation.journal | Journal Of Endourology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |